175 related articles for article (PubMed ID: 36586321)
21. Anatomical and frequencies-specific hearing results of retrograde mastoidectomy.
Demir E; Atsal G; Yildirim O; Gulustan F; Dalgic A; Catli T; Olgun L
Am J Otolaryngol; 2019; 40(3):372-376. PubMed ID: 30885447
[TBL] [Abstract][Full Text] [Related]
22. Quality of life and functional results in canal wall down vs canal wall up mastoidectomy.
Lucidi D; De Corso E; Paludetti G; Sergi B
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):53-60. PubMed ID: 30936579
[TBL] [Abstract][Full Text] [Related]
23. Canal wall down mastoidectomy with obliteration versus canal wall up mastoidectomy in primary cholesteatoma surgery.
Wilkie MD; Chudek D; Webb CJ; Panarese A; Banhegyi G
J Laryngol Otol; 2019 Dec; 133(12):1074-1078. PubMed ID: 31735175
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of cholesteatoma in children.
Göçmen H; Kiliç R; Ozdek A; Kizilkaya Z; Safak MA; Samim E
Int J Pediatr Otorhinolaryngol; 2003 Aug; 67(8):867-72. PubMed ID: 12880666
[TBL] [Abstract][Full Text] [Related]
25. Mastoid Obliteration Decreases the Recurrent and Residual Disease: Systematic Review and Meta-analysis.
Illés K; Meznerics FA; Dembrovszky F; Fehérvári P; Bánvölgyi A; Csupor D; Hegyi P; Horváth T
Laryngoscope; 2023 Jun; 133(6):1297-1305. PubMed ID: 36169349
[TBL] [Abstract][Full Text] [Related]
26. Mastoid obliteration with S53P4 bioactive glass after canal wall down mastoidectomy: Preliminary results.
Król B; Cywka KB; Skarżyńska MB; Skarżyński PH
Am J Otolaryngol; 2021; 42(2):102895. PubMed ID: 33429176
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of pediatric cholesteatomas.
Shirazi MA; Muzaffar K; Leonetti JP; Marzo S
Laryngoscope; 2006 Sep; 116(9):1603-7. PubMed ID: 16954988
[TBL] [Abstract][Full Text] [Related]
28. Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration.
Kroon VJ; Mes SW; Borggreven PA; van de Langenberg R; Colnot DR; Quak JJ
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1713-1722. PubMed ID: 36208330
[TBL] [Abstract][Full Text] [Related]
29. Trans-canal endoscopic ear surgery and canal wall-up tympano-mastoidectomy for pediatric middle ear cholesteatoma.
Glikson E; Feinmesser G; Sagiv D; Wolf M; Migirov L; Shapira Y
Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3021-3026. PubMed ID: 31377903
[TBL] [Abstract][Full Text] [Related]
30. The impact of middle ear aeration on surgical outcome after intact canal wall tympanoplasty for cholesteatoma.
Motegi M; Yamamoto Y; Ouchi K; Akutsu T; Tada T; Kurihara S; Takahashi M; Sampei S; Sano H; Morino T; Komori M; Yamamoto K; Sakurai Y; Kojima H
Auris Nasus Larynx; 2020 Dec; 47(6):965-975. PubMed ID: 32646631
[TBL] [Abstract][Full Text] [Related]
31. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
Kim CW; Oh JI; Choi KY; Park SM; Park MI
Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
[TBL] [Abstract][Full Text] [Related]
32. Tympanoplasty with intact canal wall mastoidectomy for cholesteatoma: long-term surgical outcomes.
Wilson KF; Hoggan RN; Shelton C
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):292-5. PubMed ID: 23674568
[TBL] [Abstract][Full Text] [Related]
33. Canal wall down versus canal wall up surgeries in the treatment of middle ear cholesteatoma.
Karamert R; Eravcı FC; Cebeci S; Düzlü M; Zorlu ME; Gülhan N; Tutar H; Uğur MB; İriz A; Bayazıt YA
Turk J Med Sci; 2019 Oct; 49(5):1426-1432. PubMed ID: 31651106
[TBL] [Abstract][Full Text] [Related]
34. [Analyses of the operative efficacy of 102 cases of acquired middle ear cholesteatoma].
Yang B; Jiang X; Yang N; Hui L; Wang B; Sun Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):338-42. PubMed ID: 27220292
[TBL] [Abstract][Full Text] [Related]
35. Trends and Healthcare Use Following Different Cholesteatoma Surgery Types in a National Cohort, 2003-2019.
Qian ZJ; Tran ED; Alyono JC; Cheng AG; Ahmad IN; Chang KW
Otol Neurotol; 2021 Oct; 42(9):e1293-e1300. PubMed ID: 34310551
[TBL] [Abstract][Full Text] [Related]
36. Functional results after cholesteatoma surgery in an adult population using the retrograde mastoidectomy technique.
Minovi A; Venjacob J; Volkenstein S; Dornhoffer J; Dazert S
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):495-501. PubMed ID: 23529744
[TBL] [Abstract][Full Text] [Related]
37. Use of bonalive in obliterative mastoidectomy: anatomical results and clinical outcome.
Fassone E; Fabiano B; Caracciolo A; Sapino S; Ferrero V
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3577-3583. PubMed ID: 36917252
[TBL] [Abstract][Full Text] [Related]
38. Type III tympanoplasty with titanium total ossicular replacement prosthesis: anatomic and functional results.
Iñiguez-Cuadra R; Alobid I; Borés-Domenech A; Menéndez-Colino LM; Caballero-Borrego M; Bernal-Sprekelsen M
Otol Neurotol; 2010 Apr; 31(3):409-14. PubMed ID: 20042992
[TBL] [Abstract][Full Text] [Related]
39. Cost analysis and outcomes of a second-look tympanoplasty-mastoidectomy strategy for cholesteatoma.
Crowson MG; Ramprasad VH; Chapurin N; Cunningham CD; Kaylie DM
Laryngoscope; 2016 Nov; 126(11):2574-2579. PubMed ID: 26928951
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the SAMEO-ATO surgical classification in a Dutch cohort.
Ten Tije FA; Alkema S; van der Putten L; Koopman JP; Buwalda J; Kramer SE; Pauw RJ; Merkus P;
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):653-658. PubMed ID: 32529402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
